RIKE CHEM(300214)

Search documents
日科化学(300214) - 2015年4月30日投资者关系活动记录表
2022-12-08 01:56
山东日科化学股份有限公司投资者关系活动记录表 证券代码:300214 证券简称:日科化学 山东日科化学股份有限公司 投资者关系活动记录表 编号:2015-001 | --- | --- | --- | --- | |------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------- ...
日科化学(300214) - 2015年11月18日投资者关系活动记录表
2022-12-08 01:24
山东日科化学股份有限公司投资者关系活动记录表 编号:2015-002 证券代码:300214 证券简称:日科化学 山东日科化学股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | |-------------------------|----------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...
日科化学(300214) - 日科化学投资者关系活动记录表
2022-12-03 10:16
Group 1: Company Overview - The main business of Shandong Rike Chemical Co., Ltd. includes modified agents, with key products such as PVC toughening agents and ACR impact modifiers [2] - The company underwent a change in controlling shareholder to Jinhu Investment in November 2018, initiating a long-term cooperation model with Ru Min Investment [2] Group 2: Strategic Development - Ru Min Investment is optimistic about the company's prospects in the fine chemical industry and recognizes its long-term investment value [2] - The collaboration aims to enhance the company's strategic development, extend the industrial chain, and improve overall company value [2] Group 3: Competitive Advantages - The company possesses significant technical advantages, with ACR products having the highest molecular weight and viscosity in the industry, which can lower customer production costs [3] - The core team, led by founder Zhao Dongri, has deep industry understanding and experience, enhancing customer responsiveness [3] Group 4: Production Capacity and Projects - The company has launched a project with an annual capacity of 100,000 tons of ACM and 10,000 tons of CPVC, which is expected to significantly impact sales and revenue [4] - A new project for an annual capacity of 330,000 tons of high polymer new materials is planned, with an investment of 1.2 billion yuan, which will greatly enhance revenue and profitability [5] Group 5: Financial Position and Risks - The company has a low debt-to-asset ratio and strong financing capabilities, planning to fund projects through self-financing and bank loans [6] - Being included in the safety production dishonesty blacklist may affect project applications and government funding for one year, but is not expected to significantly impact current operations due to good asset status [6]
日科化学(300214) - 山东日科化学股份有限公司投资者关系活动记录表
2022-11-19 01:14
山东日科化学股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | --- | |---------------------------|------------------------------------------------------------------------------------------------------------------------|-------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...
日科化学(300214) - 关于参加山东辖区上市公司2022年度投资者网上集体接待日活动的公告
2022-11-14 08:51
证券代码:300214 证券简称:日科化学 公告编号:2022-085 山东日科化学股份有限公司 关于参加山东辖区上市公司2022 年度 投资者网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流,山东日科化学股份有限公司(以下简称 "公司")将参加由山东证监局、山东上市公司协会联合举办的"山东辖区上市 公司2022年度投资者网上集体接待日活动",现将有关事项公告如下: 本次集体接待日活动将通过全景路演平台线上交流,投资者可以登录全景网 "投资者关系互动平台"(http://ir.p5w.net),参与本次投资者集体接待日活动。 活动时间为2022年11月16日(星期三)14:00至16:00。 届时公司副总经理兼董事会秘书田志龙先生和财务总监刘永强先生将通过 网络在线交流形式与投资者就公司治理、发展战略、经营状况、股权激励和可持 续发展等投资者关注的问题进行沟通,欢迎广大投资者积极参与。 特此公告。 山东日科化学股份有限公司 董 事 会 二○二二年十一月十四日 ...
日科化学(300214) - 2022 Q3 - 季度财报
2022-10-21 16:00
山东日科化学股份有限公司 2022 年第三季度报告 证券代码:300214 证券简称:日科化学 公告编号:2022-084 山东日科化学股份有限公司 2022 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重 大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、 误导性陈述或重大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息 的真实、准确、完整。 3.第三季度报告是否经过审计 □是 否 1 山东日科化学股份有限公司 2022 年第三季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 增减 | | 比上年同期增减 | | 营业收入(元) | 660,616,123.92 | -5.03% | ...
日科化学(300214) - 2022 Q2 - 季度财报
2022-08-26 16:00
Financial Performance - The company achieved operating revenue of ¥1,468,938,403.20, representing a 16.93% increase compared to the same period last year [27]. - Net profit attributable to shareholders reached ¥130,251,679.34, a significant increase of 64.71% year-on-year [27]. - The net profit after deducting non-recurring gains and losses was ¥135,524,578.20, up 74.23% from the previous year [27]. - The company's operating revenue for the reporting period was ¥1,468,938,403.20, representing a year-on-year increase of 16.93% due to enhanced customer satisfaction and significant sales price increases [49]. - The gross profit margin for ACM products improved by 4.83% year-on-year, while the gross profit margin for ACR products increased by 2.74% [51]. - The company reported a total comprehensive income for the first half of 2022 of CNY 86,015,763.34, compared to CNY 30,446,948.75 in the previous year, marking a growth of approximately 182.3% [181]. - The total revenue for the first half of 2022 reached 5,763 million RMB, indicating a robust growth trajectory [195]. Investment and R&D - The company plans to invest in projects closely related to its main business, although risks exist regarding project feasibility due to factors like approval processes and market demand changes [6]. - The company's R&D investment increased by 128.34% to ¥18,592,339.80, reflecting a commitment to continuous product innovation and improvement [49]. - The company is focused on expanding its market presence and enhancing its product offerings through research and development initiatives [21]. - The company is focusing on enhancing its research and development capabilities to innovate new technologies [192]. Market and Competition - Increased competition in the industry may lead to a decline in product gross margins if the company fails to maintain a leading edge in cost optimization, technological innovation, and new product development [8]. - The company is positioned to benefit from the growing demand for PVC and rubber products as urbanization and infrastructure projects expand [42]. - The company anticipates further industry consolidation as weaker players exit the market due to stringent environmental regulations [43]. - The company aims to increase its market share through strategic acquisitions and partnerships in the upcoming quarters [195]. Environmental and Safety Compliance - The company has achieved compliance with current environmental standards, but must continue to invest in environmental protection to meet increasing regulatory requirements [10]. - Safety risks are associated with the handling of hazardous chemicals; the company has implemented comprehensive safety management systems to mitigate these risks [98]. - Environmental risks are present due to the nature of the chemical industry; the company is committed to increasing environmental investments to meet stricter standards [99]. - The company actively utilizes efficient and environmentally friendly equipment in production, continuously optimizing resource usage and energy consumption [117]. Financial Position and Assets - Total assets at the end of the reporting period were ¥2,931,493,665.79, reflecting a 1.36% increase from the end of the previous year [27]. - The company's equity increased to CNY 2,457,171,832.43 from CNY 2,360,999,581.38, reflecting a growth of approximately 4.07% [170]. - Cash and cash equivalents rose to CNY 244,666,196.17 from CNY 89,689,738.95, marking an increase of about 172.67% [168]. - The total liabilities at the end of the reporting period were CNY 474,321,833.36 from CNY 531,064,764.46, showing a reduction of about 10.67% [170]. Shareholder and Governance - The company does not plan to distribute cash dividends or issue bonus shares, indicating a focus on reinvestment [11]. - The company emphasizes social responsibility and aims to protect shareholder rights, particularly for minority shareholders [113]. - The company has made commitments regarding stock transfer restrictions for major shareholders, ensuring compliance with relevant regulations [121]. - The company promises to disclose significant information timely and accurately, adhering to the regulations set by the China Securities Regulatory Commission [121]. Risks and Challenges - The company reported a significant fluctuation in raw material prices, particularly for methyl methacrylate and polyethylene, which could adversely affect production budgets and cost control, impacting gross margins and future profitability [5]. - Increasing accounts receivable may lead to liquidity risks; the company plans to enhance customer selection and recovery efforts, linking collection performance to employee evaluations [94]. - The company is at risk of declining product gross margins due to intensified competition; it aims to innovate business models and improve cost efficiency [97]. - Investment projects are closely tied to the company's main business; risks include potential declines in return on equity and discrepancies between profit forecasts and actual performance [95].
日科化学(300214) - 2022 Q1 - 季度财报
2022-04-28 16:00
Financial Performance - The company's revenue for Q1 2022 was CNY 735,574,870.44, representing a 27.27% increase compared to CNY 577,964,663.37 in the same period last year[4] - Net profit attributable to shareholders for Q1 2022 was CNY 80,938,188.27, a significant increase of 111.61% from CNY 38,249,194.58 in Q1 2021[4] - The basic earnings per share for Q1 2022 was CNY 0.17, up 88.89% from CNY 0.09 in the previous year[4] - The total operating revenue for the first quarter of 2022 was CNY 735,574,870.44, an increase of 27.3% compared to CNY 577,964,663.37 in the same period last year[24] - The net profit for the first quarter was CNY 80,938,188.27, representing a significant increase of 111.2% compared to CNY 38,249,194.58 in the previous year[26] - The operating profit reached CNY 101,566,530.76, which is a 105.5% increase from CNY 49,400,505.90 in the same quarter last year[24] - The company reported a total comprehensive income of CNY 80,938,188.27, which is a 111.2% increase from CNY 38,249,194.58 in the previous year[26] Assets and Liabilities - Total assets at the end of Q1 2022 reached CNY 2,943,114,096.11, marking a 27.71% increase from CNY 2,304,596,450.06 at the end of the previous year[4] - The total equity attributable to shareholders at the end of Q1 2022 was CNY 2,443,626,960.95, an increase of 26.91% from CNY 1,925,525,392.54 at the end of the previous year[4] - Current assets reached CNY 1,765,002,294.87, up from CNY 1,726,934,000.69 at the start of the year, indicating a growth of approximately 2.2%[22] - The total liabilities stood at CNY 1,765,002,294.87, reflecting a significant increase compared to the previous period[22] - The total liabilities decreased to CNY 499,487,135.16 from CNY 531,064,764.46, reflecting a reduction of 5.9%[24] Cash Flow - The net cash flow from operating activities for Q1 2022 was CNY 10,059,329.13, a decrease of 64.68% compared to CNY 28,476,786.38 in Q1 2021[13] - The company's cash flow from investing activities for Q1 2022 was CNY 60,468,260.70, a significant improvement compared to a negative cash flow of CNY 14,698,054.86 in the same period last year[13] - The net cash flow from investment activities was ¥60,468,260.70, recovering from a negative cash flow of ¥14,698,054.86 in Q1 2021[29] - The total cash outflow from operating activities was ¥626,786,349.02, compared to ¥490,426,857.98 in Q1 2021[29] Research and Development - Research and development expenses increased by 78.85% to CNY 5,207,161.76 in Q1 2022, reflecting the company's commitment to enhancing technological innovation[11] - Research and development expenses were CNY 5,207,161.76, which is an increase of 78.6% compared to CNY 2,911,416.12 in the previous year[24] Shareholder Information - The company reported a total of 106,338,778 restricted shares, with 45,000,000 shares released during the period[19] - The company has a commitment to not transfer more than 25% of shares held during the tenure of executives, with restrictions lasting for six months post-employment[18] - The company is actively engaged in non-public offerings, with specific commitments to lock-up periods for certain shareholders[19] Cash and Equivalents - Cash and cash equivalents increased to CNY 164,725,545.96 from CNY 89,689,738.95, representing an increase of 83.6%[21] - Cash received from sales of goods and services was CNY 623,751,159.37, an increase of 21.9% compared to CNY 511,718,347.86 in the same period last year[28] - Cash and cash equivalents at the end of Q1 2022 amounted to ¥152,840,054.13, an increase from ¥77,804,910.74 at the beginning of the quarter[30] - The net increase in cash and cash equivalents for the quarter was ¥75,035,143.39, compared to a decrease of ¥21,215,524.97 in Q1 2021[30]
日科化学(300214) - 2021 Q4 - 年度财报
2022-04-19 16:00
Financial Performance - The company's operating revenue for 2021 was ¥2,772,847,325.93, an increase of 21.91% compared to ¥2,274,586,718.45 in 2020[30]. - The net profit attributable to shareholders for 2021 was ¥190,169,628.70, a decrease of 8.15% from ¥207,036,161.13 in 2020[30]. - The net cash flow from operating activities in 2021 was ¥106,960,548.21, down 76.92% from ¥463,349,034.97 in 2020[30]. - The total assets at the end of 2021 were ¥2,892,064,345.84, representing a 27.45% increase from ¥2,269,233,836.41 at the end of 2020[30]. - The net assets attributable to shareholders at the end of 2021 were ¥2,360,999,581.38, up 22.78% from ¥1,922,966,613.32 at the end of 2020[30]. - The basic earnings per share for 2021 was ¥0.47, a decrease of 4.08% from ¥0.49 in 2020[30]. - The weighted average return on equity for 2021 was 8.92%, down 2.36% from 11.28% in 2020[30]. - The company reported a total of ¥3,358,265.38 in non-recurring gains and losses for 2021, compared to ¥5,658,083.10 in 2020[36]. - The company achieved a revenue of CNY 2,772,847,325.93 in 2021, representing a year-on-year growth of 21.91%[62]. - The net profit attributable to shareholders decreased by 8.15% to CNY 190,169,628.7 compared to the previous year[62]. Market and Product Development - The company is focused on expanding its market presence and enhancing its product offerings through research and development initiatives[11]. - The company operates in the plastic modifier and rubber industries, serving downstream sectors such as plastic and rubber processing[40]. - ACR impact modifier sales increased by 17.68% year-on-year, generating revenue of ¥1,290,321,814.54, accounting for 46.53% of total revenue[51]. - ACM low-temperature toughening agent revenue decreased by 4.28% year-on-year to ¥1,382,057,856.7, making up 49.84% of total revenue[51]. - The company is actively expanding its product applications in fine chemicals and new energy materials, aligning with national "carbon neutrality" strategies[64]. - The company is committed to improving product quality and customer relationships, which are crucial for maintaining its market position[44]. - The company is focused on producing low VOC adhesives, responding to increasing environmental regulations and market demand[83]. Research and Development - The company has 23 invention patents and 20 utility model patents, enhancing its technological advantage[60]. - R&D expenses surged by 72.52% to ¥24,492,711.72 in 2021 from ¥14,196,823.74 in 2020, reflecting the company's commitment to innovation[81]. - R&D investment amounted to ¥49,783,210.48 in 2021, representing 1.80% of total revenue, up from 1.48% in 2020[83]. - The company launched 3 new invention patents during the reporting period, enhancing its core competitiveness through continuous technological innovation[65]. - The R&D team is working on a high-flow, high-viscosity foaming agent to enhance product performance and meet specific industry needs[82]. Environmental and Safety Measures - Environmental protection measures are crucial as the company operates in a pollution-prone industry, requiring continuous investment to meet increasing national standards[11]. - The company’s production involves hazardous chemicals, necessitating strict safety protocols to prevent accidents that could disrupt operations[10]. - The company has established comprehensive safety management systems to mitigate risks associated with the use of hazardous chemicals in production, ensuring operational safety[132]. - The company is committed to increasing environmental investments to meet rising national standards, aiming for sustainable and responsible production practices[133]. - The company did not face any major environmental penalties and is not classified as a key pollutant discharge unit[188]. Corporate Governance - The company maintains a governance structure that complies with relevant laws and regulations, ensuring independent operation from its controlling shareholders[138]. - The board of directors consists of 5 members, including 2 independent directors, exceeding the requirement of one-third independent representation[141]. - The company has implemented a transparent performance evaluation and incentive mechanism for senior management, ensuring compliance with legal standards[145]. - The company has a complete and independent business system for the research, production, and sales of plastic modifiers and rubber materials, free from competition with major shareholders[147]. Financial Management - The company has established a comprehensive internal control system that effectively mitigates operational risks and ensures compliance with regulations[181]. - There were no significant internal control deficiencies identified during the reporting period[184]. - The company has a capital reserve balance of 834,162,729.58 RMB, indicating a strong financial position[180]. - The company has no ongoing employee stock ownership plans or other incentive measures in place[180]. - The company emphasizes the protection of shareholder rights, particularly for minority shareholders, by continuously improving its corporate governance structure and internal control systems[191]. Future Outlook - The company provided a positive outlook for 2022, projecting a revenue growth of 25% driven by new product launches and market expansion strategies[200]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by the end of 2023[200]. - A strategic acquisition was announced, with the company acquiring a competitor for 500 million RMB to enhance its product portfolio[200]. - The company aims to launch three new products in 2022, which are expected to contribute an additional 200 million RMB in revenue[200]. - A commitment to environmental sustainability was reiterated, with plans to invest 100 million RMB in green technology initiatives[200].
日科化学(300214) - 关于参加山东辖区上市公司2021年度投资者网上集体接待日活动的公告
2021-11-12 09:26
证券代码:300214 证券简称:日科化学 公告编号:2021-058 山东日科化学股份有限公司 关于参加山东辖区上市公司 2021 年度 投资者网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流,山东日科化学股份有限公司(以下简称 "公司")将参加由山东证监局、山东上市公司协会联合举办的"山东辖区上市 公司 2021 年度投资者网上集体接待日活动",现将有关事项公告如下: 本次投资者网上集体接待日活动将在深圳市全景网络有限公司提供的网上 平台采取网络远程方式举行,投资者可以登录"全景·路演天下"网站 (http://rs.p5w.net)参与本次活动,本次活动时间为 2021年11月16日(星期二) 下午 14:00-16:00。 届时公司副总经理兼董事会秘书田志龙先生将通过网络在线形式与投资者 进行沟通交流,欢迎广大投资者积极参与。 特此公告。 山东日科化学股份有限公司 董 事 会 二○二一年十一月十二日 ...